Tamoxifen

About

Therapy type: Hormone therapy

Therapy strategy: Estrogen receptor inhibition

Mappings

NCI Thesaurus: Tamoxifen (ncit:C62078)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) ER positive, HER2-negative Invasive Breast Carcinoma Abemaciclib, Tamoxifen
Sensitivity (+) HER2-negative, PR positive Invasive Breast Carcinoma Abemaciclib, Tamoxifen
Sensitivity (+) ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Abemaciclib, Tamoxifen
Sensitivity (+) ER positive, HER2-negative Invasive Breast Carcinoma Abemaciclib, Tamoxifen
Sensitivity (+) HER2-negative, PR positive Invasive Breast Carcinoma Abemaciclib, Tamoxifen
Sensitivity (+) ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Abemaciclib, Tamoxifen
Sensitivity (+) ER positive Invasive Breast Carcinoma Tamoxifen
Sensitivity (+) ER positive Invasive Breast Carcinoma Tamoxifen
Sensitivity (+) ER positive, HER2-negative Invasive Breast Carcinoma Abemaciclib, Tamoxifen
Sensitivity (+) HER2-negative, PR positive Invasive Breast Carcinoma Abemaciclib, Tamoxifen
Sensitivity (+) ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Abemaciclib, Tamoxifen